Loading clinical trials...
Loading clinical trials...
Missed Opportunities for HIV Screening in General Practice - A Retrospective Study
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
Strasbourg, France
Start Date
April 14, 2025
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2026
Last Updated
January 5, 2026
50
ESTIMATED participants
Lead Sponsor
University Hospital, Strasbourg, France
NCT06694805
NCT04142047
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330